metastatic renal cell carcinoma

  • March 5, 2024  
  • March 5, 2024  

    How Would a Harvard Oncologist Manage His Own Metastatic Kidney Cancer?

    With: David J. Einstein, MD

    When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks kidney cancer expert David J. Einstein, MD, how he would handle his own hypothetical case of kidney cancer. Dr. Einstein is Assistant Professor of Medicine in the Genitourinary Oncology Program at Harvard Medical School’s Beth Israel Deaconess Medical Center.… Read more »

  • August 5, 2022  

    Summary of Kidney Cancer Highlights from ASCO GU 2022 Bookmark

    George Lundberg, MD

    This article from the International Kidney Cancer Coalition (IKCC) outlines updates on treatment options for renal cell carcinoma as presented at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Symposium.

    .

  • August 5, 2022  

    Good for Bladder Cancer, Better for Kidney Cancer Bookmark

    George Lundberg, MD

    This article from the National Cancer Institute’s Center for Cancer Research outlines new clinical trial results showing that combining the drugs cabozantinib and nivolumab doubled progression-free survival for people with advanced renal cell carcinoma compared to giving cabozantinib alone.

    .

  • December 13, 2019  

    New Standard of Care for Metastatic Renal Cell Carcinoma Bookmark

    George Lundberg, MD

    Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes: 

    This piece describes huge improvements in the standard of care and outcomes from combo therapy in metastatic renal cell carcinoma.

    Go to full article published by Medscape.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • June 21, 2019  

    Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies Bookmark

    George Lundberg, MD

    Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes: 

    Ageism (bias against the elderly) is a real issue in the selection of patients to be included in clinical trials. A new study demonstrates how such bias may harm the elderly with renal cell carcinoma.

    Go to full article published by Medical Xpress.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.